SCHEMBL6401816

SCHEMBL6401816

CC(C)(C)C1=CC(CC2C=C(C(C)(C)C)c3ccccc32)c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.33
GPR3 P46089 1/20 0.32
HTR2A P28223 1/20 0.32
ACHE P22303 2/20 0.31
CHRM2 P08172 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
ADRA1A P35348 1/20 0.31
OPRM1 P35372 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
SLC22A2 O15244 1/20 0.30
SLC22A3 O75751 1/20 0.30
BCHE P06276 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7767462 0.84 HTR6 (0.36) HTR6ACHEBCHE
SCHEMBL28735638 0.82 HTR6 (0.31) HTR6
SCHEMBL9550604 0.76 GPR3 (0.34) GPR3HTR2A
SCHEMBL29732984 0.74 KMT2A (0.33) GPR3ACHESLC22A2SLC22A3BCHE
SCHEMBL5702797 0.74 GPR3 (0.33) GPR3
SCHEMBL5473851 0.74 GPR3 (0.33) GPR3ACHECHRM2HTR1AADRA2A
SCHEMBL7863731 0.74 GPR3 (0.38) GPR3HTR2AACHECHRM2HTR1A
Hydrochloric Acid SCHEMBL7609107 0.73 GPR3 (0.36) GPR3
Hydrochloric Acid SCHEMBL28436054 0.73 GPR3 (0.32) GPR3
Hydrochloric Acid SCHEMBL3192369 0.73 GPR3 (0.32) GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0914323-A1 METALLOCENES AND CATALYSTS FOR POLYMERIZATION OF OLEFINS Montell Technology Company B.V. (NL) 1999-05-12 EP claimed
WO-1998043989-A1 METALLOCENES AND CATALYSTS FOR POLYMERIZATION OF OLEFINS MONTELL TECHNOLOGY COMPANY B.V. (NL) 1998-10-08 WO claimed
EP-1017729-B1 PROCESS FOR THE PREPARATION OF SUBSTANTIALLY AMORPHOUS ALPHA-OLEFIN POLYMERS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR THE PREPARATION OF BRIDGED LIGAND BASELL POLYOLEFINE GMBH (DE) 2005-09-14 EP disclosed
US-6844288-B2 Process for the preparation of ligands for metallogene catalysts BASELL POLYOLEFINE GMBH (DE) 2005-01-18 US disclosed
EP-0991677-B1 PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH ALPHA-OLEFINS BASELL POLYOLEFINE GMBH (DE) 2004-06-16 EP disclosed
US-20030158356-A1 Process for the preparation of substantially amorphous alpha-olefin polymers and compositions containing them and process for the preparation of bridged ligand EQUISTAR CHEMICALS, LP 2003-08-21 US disclosed
US-20020169260-A1 Process for the preparation of ligands for metallocene catalysts RESCONI LUIGI (IT) 2002-11-14 US disclosed
US-20020156209-A1 Polymerization in the presence of metallocene catalysts with bridged bis-indenyl compounds BASELL TECHNOLOGY COMANY BV (NL) 2002-10-24 US disclosed
EP-0979232-B1 PROCESS FOR THE PREPARATION OF METALLOCENE COMPOUNDS BASELL POLYOLEFINE GMBH (DE) 2002-10-09 EP disclosed
US-6448350-B1 Process for the preparation of copolymers of ethylene with alpha-olefins BASELL TECHNOLOGY COMPANY BV (NL) 2002-09-10 US disclosed
US-6423796-B1 COORDINATION CATALYST BASEL TECHNOLOGY COMPANY BV (NL) 2002-07-23 US disclosed
WO-2000001738-A9 PROCESS FOR THE PREPARATION OF SUBSTANTIALLY AMORPHOUS ALPHA-OLEFIN POLYMERS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR THE PREPARATION OF BRIDGED LIGAND MONTELL TECHNOLOGY COMPANY BV (NL) 2000-07-27 WO disclosed
EP-1017729-A2 PROCESS FOR THE PREPARATION OF SUBSTANTIALLY AMORPHOUS ALPHA-OLEFIN POLYMERS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR THE PREPARATION OF BRIDGED LIGAND Montell Technology Company bv (NL) 2000-07-12 EP disclosed
EP-0991677-A1 PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH ALPHA-OLEFINS Montell Technology Company bv (NL) 2000-04-12 EP disclosed
EP-0979232-A1 PROCESS FOR THE PREPARATION OF METALLOCENE COMPOUNDS Montell Technology Company B.V. (NL) 2000-02-16 EP disclosed
WO-2000001738-A2 PROCESS FOR THE PREPARATION OF SUBSTANTIALLY AMORPHOUS ALPHA-OLEFIN POLYMERS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR THE PREPARATION OF BRIDGED LIGAND MONTELL TECHNOLOGY COMPANY BV (NL) 2000-01-13 WO disclosed
WO-1999054369-A1 PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH ALPHA-OLEFINS MONTELL TECHNOLOGY COMPANY B.V. (NL) 1999-10-28 WO disclosed
WO-1999036427-A1 PROCESS FOR THE PREPARATION OF METALLOCENE COMPOUNDS MONTELL TECHNOLOGY COMPANY B.V. (NL) 1999-07-22 WO disclosed
EP-0914323-A1 METALLOCENES AND CATALYSTS FOR POLYMERIZATION OF OLEFINS Montell Technology Company B.V. (NL) 1999-05-12 EP disclosed
WO-1998043989-A1 METALLOCENES AND CATALYSTS FOR POLYMERIZATION OF OLEFINS MONTELL TECHNOLOGY COMPANY B.V. (NL) 1998-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158356-A1 Process for the preparation of substantially amorphous alpha-olefin polymers and compositions containing them and process for the preparation of bridged ligand MACF1, SDC1, SDC2 HTR6 4576/4885GPR3 3819/4885HTR2A 4160/4885
US-20020169260-A1 Process for the preparation of ligands for metallocene catalysts SDC1, SDC2, SDC4 HTR6 4211/4885GPR3 4124/4885HTR2A 3843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.